Calendar UroGen Pharma Ltd.

Equities

URGN

IL0011407140

Real-time Estimate Cboe BZX 02:05:52 2024-04-24 pm EDT 5-day change 1st Jan Change
14.38 USD -1.07% Intraday chart for UroGen Pharma Ltd. +1.69% -3.47%

Chart calendar UroGen Pharma Ltd.

250.AusyOHpCYsFnweYsYS2ZVMYs2c_uvmnWAkU1zSi5YI4.adJiXwkwKLEkhrJ4MVjfMrNfvryp8SO_YQNbgUfOFtRX3lEIGAQztxC5pw~6db0b53435cfe4d3162fd6e95deb95af

Upcoming events on UroGen Pharma Ltd.

2024-05-02 03:45 pm AUA Innovation Nexus Conference
2024-05-04 10:50 am American Urological Association Meeting - Abstract No. 24-7720
2024-05-04 03:20 pm American Urological Association Meeting - Abstract No. 24-6641
2024-05-05 12:10 pm American Urological Association Meeting - Abstract No. 24-7470
2024-05-05 12:20 pm American Urological Association Meeting - Abstract No. 24-7534
2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-03-12 Q4 2024 Earnings Release (Projected)

Past events on UroGen Pharma Ltd.

2024-03-14 10:00 am Q4 2023 Earnings Call
2024-03-14 08:00 am Q4 2023 Earnings Release
2024-03-04 01:30 pm TD Cowen Health Care Conference
2024-02-13 12:00 pm Oppenheimer Healthcare Life Sciences Conference
2024-02-08 11:00 am Guggenheim Healthcare Talks Biotechnology Conference
2024-01-18 12:00 pm B. Riley Securities Oncology Conference
2023-11-30 02:15 pm Society of Urologic Oncology Meeting - Poster Number #132
2023-11-30 12:04 pm Society Of Urologic Oncology Meeting
2023-11-14 10:00 am Q3 2023 Earnings Call
2023-11-14 08:00 am Q3 2023 Earnings Release
2023-09-26 08:45 am Cantor Global Healthcare Conference - Fireside Chat
2023-09-12 10:00 am H.C. Wainwright Global Investment Conference
2023-09-07 10:00 am Annual General Meeting
2023-08-10 10:00 am Q2 2023 Earnings Call
2023-08-10 08:00 am Q2 2023 Earnings Release
2023-07-27 10:00 am UGN-102 Phase 3 clinical trials results call
2023-06-14 04:00 pm Goldman Sachs Global Healthcare Conference
2023-06-09 12:45 pm Jefferies Global Healthcare Conference
2023-05-11 10:00 am Q1 2023 Earnings Call
2023-05-11 08:00 am Q1 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,02
0,01
50%
11,8
11,5
2.72%
48,0
48,1
-0.13%
64,4
64,8
-0.67%
82,7
81,8
1.17%

99,0

EBITDA
Million USD
Released
Forecast
Spread
-109
-109
-0.58%
-126
-130
3.16%
-91,5
-90,2
-1.34%
-78,1
-73,2
-6.66%
-64,7
-64,0
-1.16%

-86,4

EBIT
Million USD
Released
Forecast
Spread
-109
-106
-3.24%
-127
-131
3.08%
-92,3
-96,6
4.51%
-79,0
-76,4
-3.51%
-65,5
-64,3
-1.96%

-86,5

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-105
-101
-4.6%
-125
-127
1.51%
-109
-109
-0.01%
-108
-105
-3.06%
-98,3
-99,3
0.94%

-127

Net income
Million USD
Released
Forecast
Spread
-105
-101
-3.6%
-128
-129
0.17%
-111
-109
-1.76%
-109
-105
-4.37%
-102
-98,9
-3.37%

-126

EPS
USD
Released
Forecast
Spread
-5,12
-4,94
-3.72%
-5,90
-5,92
0.29%
-4,96
-4,84
-2.56%
-4,79
-4,50
-6.54%
-3,55
-3,54
-0.28%

-3,59

Announcement Date02/03/2018/03/2121/03/2216/03/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
16,2
16,5
-1.93%
13,6
15,2
-10.62%
16,6
17,3
-3.9%
16,1
20,1
-20.1%
18,1
18,5
-2.25%
17,2
17,1
0.6%
21,1
20,1
5.06%
20,9
20,0
4.1%
23,5
22,6
4.26%

21,4


25,2


25,4


27,1


32,5

EBIT
Million USD
Released
Forecast
Spread
-19,9
-22,3
10.6%
-22,0
-24,0
8.53%
-18,7
-21,0
10.86%
-18,1
-18,9
4.15%
-20,3
-17,6
-15.31%
-22,0
-22,9
3.52%
-15,4
-17,5
12.23%
-13,5
-16,8
19.42%
-14,6
-13,4
-9.21%

-20,4


-19,2


-21,8


-25,1




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-27,3
-28,2
3.15%
-28,1
-31,3
10.22%
-26,7
-27,6
3.38%
-25,1
-27,1
7.38%
-28,2
-26,1
-7.89%
-30,2
-29,2
-3.33%
-24,1
-26,4
8.73%
-21,9
-25,9
15.41%
-22,2
-23,1
3.99%

-30,1


-30,4


-32,8


-33,6




Net income
Million USD
Released
Forecast
Spread
-28,5
-27,3
-4.39%
-28,4
-30,3
6.42%
-26,7
-27,5
3.08%
-25,8
-26,7
3.21%
-28,2
-25,3
-11.86%
-30,2
-29,7
-1.69%
-24,1
-26,3
8.15%
-21,9
-26,2
16.57%
-26,0
-22,7
-14.52%

-30,3


-30,0


-32,9


-32,5




EPS
USD
Released
Forecast
Spread
-1,27
-1,20
-6.19%
-1,25
-1,34
6.86%
-1,18
-1,30
9.23%
-1,13
-1,18
4.07%
-1,22
-1,08
-13.38%
-1,30
-1,31
0.61%
-1,03
-1,13
8.44%
-0,68
-0,85
19.76%
-0,72
-0,69
-5.11%

-0,89


-0,87


-0,93


-0,91


-0,73

Announcement Date21/03/2210/05/2211/08/2210/11/2216/03/2311/05/2310/08/2314/11/2314/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. URGN Stock
  4. Calendar UroGen Pharma Ltd.